Home | Welcome to Contract Pharma   
Last Updated Sunday, September 21 2014
Print

Breaking News

Related Searches: Preclinical Development Phase II
June 24, 2014
Advances study of ISIS-TTRRx in patients with FAP  Read More »
June 24, 2014
Will leverage Mersana's Fleximer technology for multiple targets  Read More »
June 24, 2014
Aims to support data sharing of clinical trial information for research  Read More »
June 24, 2014
Uhlendorf to grow media and advocacy presence in D.C.  Read More »
June 23, 2014
Transitions compound into preclinical development  Read More »
June 23, 2014
Savage lead business development opportunities for Southeast region  Read More »
June 23, 2014
Provides drug product for Phase I trials  Read More »
June 23, 2014
New requirements cut serialization deadline to three months  Read More »
June 23, 2014
Aims to provide more efficient Phase I studies  Read More »
June 23, 2014
Expands GMP manufacturing services for APIs  Read More »
June 18, 2014
Janssen and Vertex will work together to develop, make and commercialize VX-787, a medication designed to stop replication of Influenza A virus, which is now in Phase II trials.  Read More »
June 16, 2014
Mayne Pharma has apointed Blake Cullen VP of Business Development for its U.S. generic products division.  Mr. Cullen brings over 15 years of industry experience to the position, in the areas of strategic planning, mergers and acquisitions, prod…  Read More »
June 16, 2014
Bill Simmons, who has worked in the pharmaceutical industry for 30 years, has been named president of Jubilant HollisterStier's contract operations, replacing former CEO Marcelo Morales, who has left the company.  Simmons was managing partne…  Read More »
June 16, 2014
A group of independent investors, led by the Municipal Employees' Retirement System of Michigan, has invested $9.8 million in Grand River Aseptic Manufacturing  Read More »
June 13, 2014
Validation study shows 50% reduction in QC time  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On